Monitoring Trade Between the Community and Third Countries in Drug Precursors: Initial Appraisal of the Commission's Impact Assessment
Briefing
15-03-2013
This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposal for a Regulation amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors. Drug precursors are chemical substances that may be produced for licit purposes, but which can be misused for illegal drug production. A specific regulatory framework has been set up both at international level and within the EU to prevent the diversion of drug precursors to illicit drug production.
Briefing
Dwar dan id-dokument
Tip ta’ pubblikazzjoni
Awtur
Kelma għat-tiftix
- affarijiet soċjali
- analiżi ekonomika
- DRITT
- dritt kriminali
- dritt tal-Unjoni Ewropea
- EKONOMIJA
- INDUSTRIJA
- kimika
- KUMMERĊ
- kummerċ barra l-UE
- KWISTJONIJIET SOĊJALI
- leġiżlazzjoni farmaċewtika
- liċenzja tal-esportazzjoni
- monitoraġġ tal-esportazzjoni
- politika kummerċjali
- politika tariffarja
- prodott kimiku
- proposta (UE)
- saħħa
- stimulant
- studju tal-impatt
- traffiku tad-droga
- UNJONI EWROPEA
- ġlieda kontra l-kriminalità